This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tony's Most Recent Article

Options Trade Into Ziopharm's Sarcoma Drug Study Results

02/26/13 - 11:00 AM EST

Options expert Tony Pelz says options are the best way to trade Ziopharma's looming palifosamide data.

read more >

Other Articles by Tony

Free Reports

Dynavax Options Trade for Heplisav FDA Approval Decision

02/12/13 - 08:30 AM EST

Options expert Tony Pelz offers investors a way to use options to trade Dynavax's upcoming FDA decision.

read more >
Alexza Pharma: Premium Selling Options Strategy

12/12/12 - 11:27 AM EST

A new options trade for Alexza going into an FDA drug approval decision.

read more >
Amicus: Bullish Options Trade Into Clinical Trial Catalysts

12/04/12 - 09:05 AM EST

Contributor Tony Pelz offers an options trade for those who believe Amicus shares are going higher.

read more >
Dynavax: Speculative Upside Options Trade

11/20/12 - 07:31 AM EST

How to use options to play a possible run-up in Dynavax prior to the FDA's approval decision.

read more >
Exelixis: New Drug Approval Options Trade

11/06/12 - 08:00 AM EST

Options wizard Tony Pelz suggests another way to trade Exelixis's FDA drug approval decision.

read more >
Eli Lilly: Bearish Options Trade

11/01/12 - 10:01 AM EDT

Tony Pelz offers a short-term options trade to take advantage of end-of-year selling in Eli Lilly.

read more >
Ziopharm: Options Trade for Phase III Data

10/22/12 - 08:30 AM EDT

How to play the high-risk release of results from Ziopharm's phase III study.

read more >
How to Hedge Profits in Sarepta Therapeutics

10/15/12 - 09:00 AM EDT

Options guru Tony Pelz offers options trades for those who want to protect their Sarepta profits.

read more >
NPS Pharma: Bullish Options Trade Into the Gattex FDA Panel

10/08/12 - 08:00 AM EDT

Biotech options expert Tony Pelz recommends a bullish options trade for the Oct. 16 Gattex FDA panel.

read more >
Page 1 of 2
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs